Short sellingI am considering a decline in this stock "AVGR" with the opening of the US session.
Perf Week -6.11%
Perf Month -26.38%
Perf Quarter -31.41%
Perf Half Y -55.53%
Perf Year -71.10%
Perf YTD -62.70%
AVGR trade ideas
AVGR | Incoming Rally | SqueezeAvinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.
$AVGR can rise in the next daysContextual immersion trading strategy idea.
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $1.39;
stop-loss — $1.18.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
AVGR BullishI like the gap up yesterday and the proximity to to the POC line (YTD). Also the 9ema crossed the 20ema and the current price is close to the 50sma. I feel this is a low risk entry point. Also the MACD is crossing which is very bullish.
1st target $2.20
2nd target $2.68
AVGR ready for next leg upBounced off the right spot. ER good, future good. Looking for a test of prior highs.
$AVGRBelieve it or not, AVGR has gone UP 445% in three months.
That’s why I’m gonna hold.
We have support around 1.5
AVGR Bouncing off Support, Could See $3 Zone AgainAvinger Inc. shares hit support today and saw decent growth after hours, suggesting that they could bounce higher. The MACD indicator just crossed, which is always a good sign. The RSI indicator looks bullish as well. I am expecting a bounce similar to the one we experienced on the 18th, probably not as big, but it is highly likely it will at least break $2. Good Luck!
Make sure you like and follow for more ideas like this. Also, if you like my ideas, check out @InvestorCentral, he and I have been trading together for a long time, and he has a gift for technical analysis.
AVGRTrend was up, broke down, then back up briefly, now headed back down. Where should my entry point be? Am i thinking too high with what looks like consolidation period?
Why $AVGR skyrocketed in 2021?Avinger (NASDAQ:AVGR) is seeing a massive boost to its stock on Friday after being listed as a hot penny stock to buy on Robinhood.
The recent interest in AVGR stock comes after PennyStock.com published an article about its top penny stock picks for January 2021. Avinger takes the top spot on that list with a price target of $1, which represents a 53% premium to its closing price on Thursday.
Avinger launched Tigereye in a limited release in the U.S. and Germany in the fourth quarter of 2020.
The company is planning to expand its release of the medical device in the U.S. in the first quarter of 2021.
This will have it reaching a full commercial distribution of Tigereye during this period with a national launch taking place this month.
finance.yahoo.com
$AVGR ready to explode$AVGR to be issued US Patent twitter.com
Strong indication of reversal with this catalyst.
AVGR - AVINGER INC. final sell off is doneAVGR - AVINGER INC. , final sell off under 1 $ is done, we can see high volume and nice momentum on this weekly log chart.
Is AVGR on the way to higher levels ??
Good luck and happy trading!
Another great call, 150% gain in 10 daysIt was 0.89 at JAN10th when I made the call to buy this and today it hits 2.21 at Jan 20th..!
Eventually it could go up to 12 USD per share
$AVGR - may consolidate and deserves a rest33% gains for 19 Jan 2021
Looking at how the day ended, it may be a bit exhausted, may meet some sellers in the morning.
Watching this one and setting stop loss. Tiny stocks can make a lot of money or be really annoying
Full Commercial Launch of Tigereye(TM) Image-Guided CTO CrossingAvinger Initiates Full Commercial Launch of Tigereye(TM) Image-Guided CTO Crossing Catheter
With the initiation of full commercial launch, current and prospective accounts throughout the US and Germany are now able to order the Tigereye device.
During the fourth quarter of 2020, Avinger conducted a limited launch at 12 clinical centers in the U.S. and Germany. Approximately 50 CTO cases were successfully performed, showcasing Tigereye's advanced clinical capabilities and excellent product reliability in a variety of lesion types and settings.
The limited launch program demonstrated Tigereye's strong clinical results and efficiency across a wide range of PAD cases
"We believe full commercial availability of the Tigereye device will be an important contributor to expanding our revenue growth opportunities in 2021, both in terms of attracting new Avinger user sites and supporting higher utilization per site,"
finance.yahoo.com
$AVGR Small-Cap - Goal at 1.0 Best entry 0.3RSI and MFI still moving up . its better if it gets back to 0.3 then target between 0.9-1.0 Avinger, Inc. manufactures catheter devices used to treat vascular diseases. It designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease.
AVINGER INC Breaking To New HighsAVINGER Inc has been rising quite a lot this year, but this is only the beginning. Look to target the $1.50-$2.00 zone this year.
AVGR daily - Discord pump king of kingsAVGR is one of the hot pump and dump Discord/Reddit stocks. I don't recommend playing this unless you have a 1) day trade to burn and 2) can time your entry perfectly.
Watch for volume.
I do NOT have a position and am NOT taking a position.
AVGR Stock: 6 Things to Know About ‘Robinhood’s Hot Penny Stock to Buy’ Avinger
investorplace.com
#AVGR Analysis request [Rochester Traders]Feel free to comment with a ticker, and ill check it out! - Rochester Traders
